The expression of ASCL2 was significantly correlated with the infiltration levels of CD4+ T cells, CD8+ T cells, B cells, neutrophils, and dendritic cells in various cancer types, including COAD. This evidence concerns the gene ASCL2 and colon adenocarcinoma.